T4 gp32 Protein, 500µg
To Order Contact us: lieven@wlsolutions.be
Recombinant (E.Coli) HIV-2 gp32 |
||
RP-568 | 100 ug | EUR 343.2 |
HIV-2 gp32 recombinant antigen |
||
00173-V-01mg | 0,1 mg | EUR 321 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen |
||
00173-V-1000ug | 1000 ug | EUR 1539 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen. . |
||
00173-V-100ugvial | 100ug/vial | EUR 150 |
Description: HIV-2 gp32 recombinant antigen. . |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07726 | 100µg | Ask for price |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07727 | 500µg | Ask for price |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07728 | 1000µg | Ask for price |
Recombinant (E.Coli) HIV-2 gp32, Biotin Labeled |
||
RP-569 | 50 ug | EUR 343.2 |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07729 | 100µg | Ask for price |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07730 | 500µg | Ask for price |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07731 | 1000µg | Ask for price |
Recombinant (E.Coli) HIV-2 gp32, Horseradish Peroxidase Labled |
||
RP-570 | 50 ug | EUR 343.2 |
T4 Gene 32 Protein |
||
M1232-100 | each | EUR 280.8 |
T4 DNA Ligase protein |
||
30R-2898 | 250 units | EUR 268.8 |
Description: Purified recombinant Human T4 DNA Ligase protein |
HIV1 gp160 protein |
||
30-1836 | 100 ug | EUR 1669.2 |
Description: Purified Recombinant HIV1 ADA Envelope Glycoprotein gp160 |
HIV1 gp120 protein |
||
30-AH86 | 100 ug | EUR 1585.2 |
Description: Purified full length recombinant HIV1 gp120 protein-IIIB strain |
HIV2 gp105 protein |
||
30-015001 | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV2 gp105 protein |
HIV1 gp120 protein |
||
30-12001-2 | 100 ug | EUR 846 |
Description: Purified recombinant HIV1 gp120 protein |
HIV1 gp120 protein |
||
30-12001-4 | 1 mg | EUR 7546.8 |
Description: Purified recombinant HIV1 gp120 protein (HRP) |
Human Golgi Protein 73 (GP73) Protein |
||
20-abx066897 |
|
|
Mouse Golgi Protein 73 (GP73) Protein |
||
20-abx066898 |
|
|
HIV 1 gp160 Protein |
||
abx060587-1mg | 1 mg | EUR 1128 |
HIV-1 gp41,gp120 Protein |
||
20-abx260288 |
|
|
Melanoma (gp100) Protein |
||
20-abx263540 |
|
|
HIV1 gp41 protein |
||
30R-AH026 | 1 mg | EUR 1442.4 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30R-AH030 | 100 ug | EUR 418.8 |
Description: Purified recombinant HIV2 gp36 protein |
HIV2 gp36 protein |
||
30-AH25 | 1 mg | EUR 392.4 |
Description: Purified recombinant HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-AH26 | 1 mg | EUR 396 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30-AH82 | 100 ug | EUR 356.4 |
Description: Purified recombinant HIV2 gp36 protein |
HIV2 gp36 protein |
||
30-AH82S | 100 ug | EUR 477.6 |
Description: Purified recombinant HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-AH83 | 100 ug | EUR 236.4 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30-034001 | 100 ug | EUR 690 |
Description: Purified recombinantl HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-039001 | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV1 gp41 protein |
HIV1 gp41 protein |
||
30-039001F | 1 mg | EUR 2991.6 |
Description: Purified HIV1 gp41 protein |
Human Golgi membrane protein GP73 Protein |
||
abx060158-100ug | 100 ug | EUR 1362 |
HTLV1 gp46 protein |
||
30-041001 | 100 ug | EUR 548.4 |
Description: Purified recombinant HTLV1 gp46 protein |
HTLV1 gp46 protein |
||
30-042001F | 1 mg | EUR 418.8 |
Description: Purified recombinant HTLV1 protein (gp46) |
HTLV1 gp46 protein |
||
30-043001F | 100 ug | EUR 770.4 |
Description: Purified recombinant HTLV1 gp46 protein |
HTLV1 gp21 protein |
||
30-044001 | 100 ug | EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
HTLV1 gp21 protein |
||
30-044001-LQ | 100 ug | EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
Mouse Golgi Protein 73 (GP73) Protein (Active) |
||
20-abx651342 |
|
|
HIV-1 gp120 MN Protein |
||
20-abx260008 |
|
|
HIV-1 gp120 CM Protein |
||
20-abx260013 |
|
|
HIV-1 gp41 Protein |
||
20-abx260275 |
|
|
HIV-1, gp41 Protein |
||
abx061536-1mg | 1 mg | EUR 1161.6 |
HIV-2, gp36 Protein |
||
abx061537-1mg | 1 mg | EUR 1161.6 |
HTLV I gp21 Protein |
||
abx060598-100ug | 100 ug | EUR 811.2 |
HTLV I gp46 Protein |
||
abx060599-100ug | 100 ug | EUR 811.2 |
HIV-2, gp36 Protein |
||
abx069859-1mg | 1 mg | EUR 1312.8 |
gp64 protein antibody |
||
10R-6618 | 100 ug | EUR 424.8 |
Description: Mouse monoclonal gp64 protein antibody |
gp64 protein antibody |
||
10R-6621 | 100 ug | EUR 648 |
Description: Mouse monoclonal gp64 protein antibody |
HTLV-1 gp21 Protein |
||
20-abx260284 |
|
|
HTLV-1 gp46 Protein |
||
20-abx260285 |
|
|
HTLV1 gp21 protein (HRP) |
||
65-044002 | 50 ug | EUR 853.2 |
Description: Purified recombinant HTLV1 gp21 (HRP) |
HIV-2 gp36 397 a.a Protein |
||
20-abx260283 |
|
|
Rat Glycoprotein 130 (gp130) Protein |
||
20-abx069730 |
|
|
HTLV1 gp21 protein (FITC) |
||
65-044003 | 50 ug | EUR 418.8 |
Description: Purified recombinant HTLV1 gp21 (FITC) |
HIV2 gp105 ROD protein |
||
30-015001F | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV2 gp105 protein |
HIV1 gp41 MN protein (HRP) |
||
65-040002 | 50 ug | EUR 715.2 |
Description: Purified recombinant HIV1 gp41 MN (HRP) |
Mouse Glycoprotein 130 (gp130) Protein |
||
20-abx167413 |
|
|
Human Glycoprotein 130 (gp130) Protein |
||
20-abx066881 |
|
|
Human Glycoprotein 130 (gp130) Protein |
||
20-abx066882 |
|
|
HIV Type-O gp41 Protein |
||
20-abx260281 |
|
|
HIV1 gp41 MN protein (FITC) |
||
65-040003 | 50 ug | EUR 418.8 |
Description: Purified recombinant HIV1 gp41 MN (FITC) |
HIV-1 gag p17, p24, gp120 Protein |
||
20-abx260274 |
|
|
HIV-1 gp120 LAV Protein |
||
20-abx260011 |
|
|
GP120 Recombinant Protein |
||
96-365 | 0.1 mg | EUR 619.8 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
GP120 Recombinant Protein |
||
96-366 | 0.1 mg | EUR 619.8 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
GP120 Recombinant Protein |
||
96-367 | 0.1 mg | EUR 714.3 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
Recombinant HIV-1 gp120 and gp41 Protein |
||
VAng-Lsx04597-1mg | 1 mg | EUR 637.2 |
Description: HIV type 1 Glycoprotein 120 and 41, recombinant protein from E. coli. |
HIV 1 Envelope gp41 Protein |
||
abx060584-05mg | 0.5 mg | EUR 1128 |
HIV 1 Envelope gp41 Protein |
||
abx060585-100ug | 100 ug | EUR 1296 |
HIV 2 Envelope gp36 Protein |
||
abx060591-1mg | 1 mg | EUR 1629.6 |
HIV 2 Envelope gp36 Protein |
||
abx060592-100ug | 100 ug | EUR 1279.2 |
HIV2 gp105 ROD protein (FITC) |
||
65-015003F | 1 mg | EUR 457.2 |
Description: Purified HIV2 gp105 protein (ROD) (FITC) |
VCAP18/GP125 fusion protein |
||
30-1296 | 1 mg | EUR 4177.2 |
Description: Purified recombinant VCAP18/GP125 fusion protein |
Recombinant HIV gp41, O Group gp41, gp36 Protein |
||
VAng-0540Lsx-inquire | inquire | Ask for price |
Description: HIV Chimeric Recombinant protein containing gp41 (a.a. 546 to 692), O Group gp41 Segment, gp36 Segment (a.a. 591 to 617), recombinant protein from E. coli. |
Synthetic HIV-2 gp36 Protein |
||
20-abx260067 |
|
|
HIV2 gp105 ROD protein (biotin) |
||
65-015005 | 50 ug | EUR 289.2 |
Description: Purified recombinant HIV2 gp105 ROD (biotin) |
Recombinant HIV-1 gp120 Protein (aa 29-503) [His] |
||
VAng-Wyb7316-100g | 100 µg | EUR 2096.4 |
Description: Human Immunodeficiency Virus (group M, subtype CRF07_BC) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 29-503) [His] |
||
VAng-Wyb7316-20g | 20 µg | EUR 814.8 |
Description: Human Immunodeficiency Virus (group M, subtype CRF07_BC) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 29-503) [His] |
||
VAng-Wyb7316-50g | 50 µg | EUR 1455.6 |
Description: Human Immunodeficiency Virus (group M, subtype CRF07_BC) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 38-527) [His] |
||
VAng-Wyb7318-100g | 100 µg | EUR 2096.4 |
Description: Human Immunodeficiency Virus (group P, strain RBF168) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 38-527) [His] |
||
VAng-Wyb7318-20g | 20 µg | EUR 814.8 |
Description: Human Immunodeficiency Virus (group P, strain RBF168) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 38-527) [His] |
||
VAng-Wyb7318-50g | 50 µg | EUR 1455.6 |
Description: Human Immunodeficiency Virus (group P, strain RBF168) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-509) [His] |
||
VAng-Wyb7319-100g | 100 µg | EUR 2096.4 |
Description: Human Immunodeficiency Virus (group M, subtype B, strain SHIV-89.6P) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-509) [His] |
||
VAng-Wyb7319-20g | 20 µg | EUR 814.8 |
Description: Human Immunodeficiency Virus (group M, subtype B, strain SHIV-89.6P) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-509) [His] |
||
VAng-Wyb7319-50g | 50 µg | EUR 1455.6 |
Description: Human Immunodeficiency Virus (group M, subtype B, strain SHIV-89.6P) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-494) [His] |
||
VAng-Wyb7320-100g | 100 µg | EUR 2096.4 |
Description: Human Immunodeficiency Virus (group M, subtype A, isolate 92RW020) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-494) [His] |
||
VAng-Wyb7320-20g | 20 µg | EUR 814.8 |
Description: Human Immunodeficiency Virus (group M, subtype A, isolate 92RW020) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 31-494) [His] |
||
VAng-Wyb7320-50g | 50 µg | EUR 1455.6 |
Description: Human Immunodeficiency Virus (group M, subtype A, isolate 92RW020) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 30-509) [His] |
||
VAng-Wyb7321-100g | 100 µg | EUR 2096.4 |
Description: Human Immunodeficiency Virus (group M, subtype B, isolate BAL) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 30-509) [His] |
||
VAng-Wyb7321-20g | 20 µg | EUR 814.8 |
Description: Human Immunodeficiency Virus (group M, subtype B, isolate BAL) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-1 gp120 Protein (aa 30-509) [His] |
||
VAng-Wyb7321-50g | 50 µg | EUR 1455.6 |
Description: Human Immunodeficiency Virus (group M, subtype B, isolate BAL) envelope glycoprotein gp120, recombinant protein. |
Recombinant HIV-2 gp36 Protein |
||
VAng-0539Lsx-inquire | inquire | Ask for price |
Description: HIV type 2 gp36 Antigen, recombinant protein from Pichia pastoris. 1.30 mg/mL. |
HIV-1 gp120 nef Mosaic Protein |
||
20-abx260272 |
|
|
Inactivated EBV gp125 VCA Protein |
||
VAng-Lsx04574-1mL | 1 mL | EUR 423.6 |
Description: Epstein-Barr Virus (Strain P3HR1) gp125 VCA, inactivated antigen. |
Inactivated EBV gp125 VCA Protein |
||
VAng-Lsx04574-25mL | 25 mL | EUR 7318.8 |
Description: Epstein-Barr Virus (Strain P3HR1) gp125 VCA, inactivated antigen. |
Recombinant HIV-2 gp36 Protein [His] |
||
VAng-0528Lsx-inquire | inquire | Ask for price |
Description: HIV type 2 gp36 Antigen, recombinant protein from E. coli, MW 20.775 Da, 1.74 mg/mL. |
Recombinant HIV-1 gp41 Protein [His] |
||
VAng-0529Lsx-inquire | inquire | Ask for price |
Description: HIV type 1 gp41 Antigen, recombinant protein from E. coli, MW 18.648 Da, 1.83 mg/mL. |
Rabbit Anti HIV-1 gp120 protein IgG, clone 2 |
||
AB-21010-2 | 100 ul | EUR 562.8 |
HIV1 gp160 IIIB soluble protein (HRP) |
||
65-024102 | 50 ug | EUR 300 |
Description: Purified recombinant HIV1 gp160 (HRP) |
HIV gp41 Type O Protein |
||
abx060580-100ug | 100 ug | EUR 886.8 |
HIV-2 gp36 seq Protein |
||
abx060593-1mg | 1 mg | EUR 427.2 |
HIV-1 gp120 V3 loop region Protein |
||
abx060582-1mg | 1 mg | EUR 1312.8 |
G7P1 Protein Vector (Human) (pPM-C-HA) |
||
PV079807 | 500 ng | Ask for price |